Streetbeat News

Stock Prices

CSL

Carlisle Companies (NYSE:CSL) has significantly outperformed the market over the past decade, with an average annual return of 16.84%. A $100 investment in CSL 10 years ago would now be worth $476.06, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 8:30 pm

ACB

CGC

CURR

EAST

SNDL

TLRY

XXII

On September 9, 2024, several marijuana stocks experienced significant price movements. Notable gainers included CLS Holdings USA, Target Group, and 22nd Century Group, while major losers included Plant Based Investment and AusCann Group Holdings.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 8:30 pm

AMZN

GOOGL

ORCL

Oracle Corporation reported strong Q1 financial results, beating analyst estimates with earnings of $1.39 per share and revenue of $13.307 billion. The company announced significant partnerships with AWS and Google Cloud, enhancing its cloud services offerings. Oracle shares rose 9.25% in after-hours trading.

Portfolio Pulse from Erica Kollmann

September 09, 2024 | 8:28 pm

IONS

Ionis Pharmaceuticals shares fell following the announcement of a $500 million public offering of common stock, which may dilute existing shareholders' value.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:25 pm

LUNG

Pulmonx Corporation presented positive clinical data from the AeriSeal CONVERT trial and 5-year follow-up data from the LIBERATE study at the European Respiratory Society Congress 2024. The data showed the safety and effectiveness of the AeriSeal System and the long-term benefits of Zephyr Valves.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:25 pm

GS

Goldman Sachs CEO David Solomon announced that the trading business is expected to decline by nearly 10% in Q3, while the investment banking sector is showing signs of improvement.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:23 pm

PSN

Parsons Corporation (PSN) will be added to the S&P Midcap 400 Index, effective before the market opens on September 23, 2024. This inclusion may increase the stock's visibility and attract more institutional investors.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:23 pm

IONS

Ionis Pharmaceuticals has announced a $500 million public offering of common stock, which could impact its stock price and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:20 pm

AVO

Mission Produce shares rose following the release of their Q3 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:20 pm

SNY

Sanofi shares declined following Vir Biotechnology's announcement of an exclusive license agreement with the company.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:19 pm